Jennison Associates’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,970
Closed -$655K 603
2022
Q2
$655K Sell
5,970
-3,629
-38% -$359K ﹤0.01% 571
2022
Q1
$1M Buy
9,599
+468
+5% +$48.6K ﹤0.01% 560
2021
Q4
$1.12M Sell
9,131
-6,613
-42% -$734K ﹤0.01% 598
2021
Q3
$1.81M Buy
15,744
+1,346
+9% +$143K ﹤0.01% 551
2021
Q2
$1.4M Buy
+14,398
New +$1.25M ﹤0.01% 592
2021
Q1
Sell
-16,422
Closed -$1.12M 665
2020
Q4
$1.12M Sell
16,422
-4,767
-22% -$311K ﹤0.01% 577
2020
Q3
$1.24M Buy
21,189
+6,322
+43% +$333K ﹤0.01% 536
2020
Q2
$673K Buy
14,867
+1,524
+11% +$72.9K ﹤0.01% 566
2020
Q1
$771K Buy
+13,343
New +$913K ﹤0.01% 512

Other funds holding AMN

Jennison Associates's AMN Position: Q3 2022 in Review

Jennison Associates sold out of AMN Healthcare (AMN) in Q3 2022, closing a stake of 5,970 shares — an estimated $655K sold.

Jennison Associates first reported a position in AMN in Q1 2020 and held it in 9 quarters. The position peaked at $1.81M in Q3 2021. 463 funds tracked by Wall St. Rank hold AMN as of Q3 2022.

  • Jennison Associates reported no remaining AMN Healthcare position as of Q3 2022 after selling out during the quarter.
  • Jennison Associates sold 5,970 AMN Healthcare shares in Q3 2022, an estimated $655K.
  • Jennison Associates first reported a position in AMN Healthcare in Q1 2020 and held it in 9 quarters.
  • Jennison Associates's AMN Healthcare position peaked at $1.81M in Q3 2021.
  • 463 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2022.

Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.